日科化学(300214) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥931,593,350.81, representing a 53.56% increase compared to ¥606,662,875.55 in the same period last year[5] - The net profit attributable to shareholders was a loss of ¥8,634,199.21, slightly improved from a loss of ¥8,713,724.13 in the previous year, showing a 0.91% decrease in loss[5] - The net profit for the current period was a loss of ¥10,570,746.09, compared to a loss of ¥8,255,402.63 in the previous period, indicating a worsening financial performance[23] Cash Flow - The net cash flow from operating activities was ¥14,078,377.49, a significant turnaround from a negative cash flow of ¥121,522,266.60 in the same period last year, marking an improvement of 111.59%[5] - Cash inflows from operating activities totaled ¥825,260,614.03, compared to ¥511,584,934.48 in the previous period, showing improved cash generation[25] - The company reported a significant increase in sales revenue, with cash received from sales reaching ¥789,921,923.77, up from ¥495,248,355.04[25] Expenses and Costs - Research and development expenses increased by 55.22% to ¥10,497,948.64, reflecting the company's commitment to innovation[11] - Total operating costs amounted to ¥951,530,143.58, up 55.5% from ¥611,694,418.46 in the prior period, with operating costs specifically rising from ¥565,558,054.91 to ¥888,955,004.77[22] - The gross profit margin was impacted by a 57.18% increase in operating costs, which reached ¥888,955,004.77, driven by market expansion and increased sales volume[11] Assets and Liabilities - The total assets at the end of the reporting period were ¥5,023,139,527.90, down 2.94% from ¥5,175,069,491.29 at the end of the previous year[5] - The company’s total liabilities increased, with current liabilities rising by 31.03% to ¥239,578,613.79, reflecting a shift in long-term borrowings to current liabilities[9] - The total liabilities decreased slightly from ¥2,603,362,125.46 to ¥2,464,494,018.30, indicating improved financial stability[22] Shareholder Information - The total number of common shareholders at the end of the reporting period is 20,517[15] - The largest shareholder, Tai'an Lumin Investment Jinhu Partnership, holds 13.34% of shares, totaling 62,067,859 shares, with 21,358,823 shares pledged[15] - The total number of preferred shareholders at the end of the reporting period is 0[16] Investment and Financing - The company’s long-term equity investments rose by 36.72% to ¥10,101,268.05, attributed to increased capital in joint ventures and recognized investment income[9] - The company reported a significant increase in financial expenses by 486.58% to ¥9,861,122.03, primarily due to a larger financing scale compared to the previous period[11] - The net cash flow from financing activities was -$47,887,376.80, a decrease from $298,188,517.11 in the prior period, reflecting a shift in financing strategy[26] Other Financial Metrics - The company received government subsidies amounting to ¥2,462,799.31, contributing positively to its financial performance[7] - The company did not undergo an audit for the first quarter report, which may affect investor confidence in the financial statements[27]